Skip navigation
Agenda

Stay on the Pulse of Critical Updates for New and Proposed Changes

November 20-21, 2019
  • Alexandria, VA

Agenda

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, NOVEMBER 20, 2019

7:30

Conference Registration and Networking Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Mallory O’Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals

AN UPDATE FROM WASHINGTON

8:45

STATE OF THE INDUSTRYPolitical and Legislative Trends Impacting Healthcare Coverage and Access

Naomi Lopez  
Director of Healthcare Policy
Goldwater Institute

9:30

Navigate Legislative Proposals to Lower Drug Pricing

J.P. Paluskiewicz
Chief Minority Health Counsel, Energy & Commerce Committee
U.S. House of Representatives

10:30

Networking and Refreshment Break

2020 STRATEGIC PERSPECTIVES

11:00

Discuss State Efforts on Drug Pricing Transparency for 2020

Mallory O’Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals

Kristin Borowski
Senior Manager, State Government Affairs, State Policy
Bristol-Myers Squibb

11:45

Insights from an Actuary on Medicare Part D

David Mike, FSA, MAAA
Consulting Actuary
Milliman

12:15

Networking Luncheon

INTERNATIONAL PRICE INDEX MODEL SPOTLIGHT

1:30

Update on the International Price Index (IPI) Model and the Favored-Nations Clause

Kelsey Lang
Director, Federal Policy and Government Affairs
Bristol-Myers Squibb

Katie Verb
Director, Policy and Research
PhRMA

2:15

Discuss the Impact of the IPI on Patients, Outcomes and Innovation

Duane Schulthess
Managing Director
Vital Transformation

3:00

Networking and Refreshment Break

MEDICARE PART D — FORECASTE THE FUTURE

3:30

Strengthening Medicare Part D for Patients

Robert Popovian, Pharm.D., M.S.
Vice President, U.S. Government Relations
Pfizer Inc

4:15

Assess the Future of Medicare Part D 2.0

Tara O’Neill Hayes
Deputy Director, Health Care Policy
American Action Forum

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, NOVEMBER 21, 2019

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Mallory O’Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals

CONSIDERATIONS FOR POLICY AND REFORM

8:45

Analyze the Impact of Medicare Reform on Health Plans

Pritpal Virdee
Senior Vice President and Chief Operating Officer,
Senior Health Services
Blue Cross Blue Shield Michigan (invited)

9:20

GAO Address - Trends and Insights into Medicare Part D Drug Spending and PBM Use

John Dicken
Director, Health Care, Public Health & Private Markets
U.S. Government Accountability Office

9:50

Keep Pace with ICER Policies

Lisa Kennedy, Ph.D.
Managing Principal & Chief Economist
Innopiphany LLC

10:15

Networking and Refreshment Break

10:45

Outlook on Value-Based Contracting — Market Realities and Considerations

Christian Springer
Associate
Foley Hoag LLP

Erik Schulwolf
Associate
Foley Hoag LLP

11:45

Rebates and Pricing at the Point-of-Sale — What’s Next?

David Farber
Partner
King & Spalding

12:30

Close of Conference

Agenda

Want more agenda details? Download the brochure.

Want more agenda details? Download the brochure.

DAY ONE WEDNESDAY, NOVEMBER 20, 2019

7:30

Conference Registration and Networking Breakfast

8:30

Chairperson’s Welcome and Opening Remarks

Mallory O’Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals

AN UPDATE FROM WASHINGTON

8:45

STATE OF THE INDUSTRYPolitical and Legislative Trends Impacting Healthcare Coverage and Access

Naomi Lopez  
Director of Healthcare Policy
Goldwater Institute

9:30

Navigate Legislative Proposals to Lower Drug Pricing

J.P. Paluskiewicz
Chief Minority Health Counsel, Energy & Commerce Committee
U.S. House of Representatives

10:30

Networking and Refreshment Break

2020 STRATEGIC PERSPECTIVES

11:00

Discuss State Efforts on Drug Pricing Transparency for 2020

Mallory O’Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals

Kristin Borowski
Senior Manager, State Government Affairs, State Policy
Bristol-Myers Squibb

11:45

Insights from an Actuary on Medicare Part D

David Mike, FSA, MAAA
Consulting Actuary
Milliman

12:15

Networking Luncheon

INTERNATIONAL PRICE INDEX MODEL SPOTLIGHT

1:30

Update on the International Price Index (IPI) Model and the Favored-Nations Clause

Kelsey Lang
Director, Federal Policy and Government Affairs
Bristol-Myers Squibb

Katie Verb
Director, Policy and Research
PhRMA

2:15

Discuss the Impact of the IPI on Patients, Outcomes and Innovation

Duane Schulthess
Managing Director
Vital Transformation

3:00

Networking and Refreshment Break

MEDICARE PART D — FORECASTE THE FUTURE

3:30

Strengthening Medicare Part D for Patients

Robert Popovian, Pharm.D., M.S.
Vice President, U.S. Government Relations
Pfizer Inc

4:15

Assess the Future of Medicare Part D 2.0

Tara O’Neill Hayes
Deputy Director, Health Care Policy
American Action Forum

5:00

Close of Day One

Networking, Wine and Cheese Reception immediately following the final session on day one

DAY TWO THURSDAY, NOVEMBER 21, 2019

8:00

Continental Breakfast

8:30

Chairperson’s Review of Day One

Mallory O’Connor
Director, Public Policy
Mallinckrodt Pharmaceuticals

CONSIDERATIONS FOR POLICY AND REFORM

8:45

Analyze the Impact of Medicare Reform on Health Plans

Pritpal Virdee
Senior Vice President and Chief Operating Officer,
Senior Health Services
Blue Cross Blue Shield Michigan (invited)

9:20

GAO Address - Trends and Insights into Medicare Part D Drug Spending and PBM Use

John Dicken
Director, Health Care, Public Health & Private Markets
U.S. Government Accountability Office

9:50

Keep Pace with ICER Policies

Lisa Kennedy, Ph.D.
Managing Principal & Chief Economist
Innopiphany LLC

10:15

Networking and Refreshment Break

10:45

Outlook on Value-Based Contracting — Market Realities and Considerations

Christian Springer
Associate
Foley Hoag LLP

Erik Schulwolf
Associate
Foley Hoag LLP

11:45

Rebates and Pricing at the Point-of-Sale — What’s Next?

David Farber
Partner
King & Spalding

12:30

Close of Conference